RKDA
Arcadia Biosciences Inc
NASDAQ: RKDA · CONSUMER DEFENSIVE · PACKAGED FOODS
$1.05
-0.94% today
Updated 2026-04-30
Market cap
$2.20M
P/E ratio
—
P/S ratio
0.45x
EPS (TTM)
$-1.71
Dividend yield
—
52W range
$1 – $6
Volume
0.0M
Arcadia Biosciences Inc (RKDA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.59M | $-9.74M | $-14.79M | $-15.11M | $-17.05M | $-13.96M | $-13.63M | $-17.20M | $-30.22M | $-25.87M | $-13.98M | $-15.29M | $-9.63M | $-4.74M |
| Capital expenditures | $286000.00 | $100000.00 | $148000.00 | $151000.00 | $231000.00 | $79000.00 | $250000.00 | $1.48M | $2.33M | $1.01M | $72000.00 | $5000.00 | $16000.00 | $0.00 |
| Depreciation | $378000.00 | $391000.00 | $358000.00 | $294000.00 | $304000.00 | $279000.00 | $154000.00 | $194000.00 | $662000.00 | $1.04M | $479000.00 | $287000.00 | $765000.00 | — |
| Stock-based comp | $1.25M | $1.28M | $976000.00 | $1.39M | $1.06M | $1.47M | $1.55M | $2.29M | $2.04M | $1.54M | $1.11M | $717000.00 | $512000.00 | $234000.00 |
| Free cash flow | $-9.87M | $-9.85M | $-14.94M | $-15.26M | $-17.29M | $-14.04M | $-13.88M | $-18.68M | $-32.55M | $-26.88M | $-14.05M | $-15.30M | $-9.64M | $-4.74M |
| Investing cash flow | $-285000.00 | $-600000.00 | $-1.59M | $-46.36M | $-5.30M | $47.18M | $-5.97M | $-8.37M | $17.28M | $16.61M | $1.42M | $-4.34M | $7.34M | — |
| Financing cash flow | $8.00M | $7.83M | $30.11M | $68.87M | $396000.00 | $-26.10M | $22.48M | $21.99M | $20.56M | $21.90M | $4.52M | $5.51M | $9000.00 | — |
| Dividends paid | — | — | — | $197000.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $7.40M | $-21.96M | $7.11M | $2.87M | $-3.58M | $7.63M | — | — | — | — | — |